AVIR Other Income/Expenses (Net)

Atea Pharmaceuticals Inc · Other Income/Expenses (Net)

AVIR logo

AVIR Other Income/Expenses (Net)

Latest reported$11.82M
AVIR TTM Other Income/Expenses (Net) ($574.00K → $11.82M)
High-resolution chart · PNG

AVIR other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
11,821,000
14,022,000
16,376,000
18,785,000
21,348,000
23,594,000
25,490,000
27,540,000
29,127,000
29,793,000
29,224,000
27,057,000
23,575,000
17,352,000
11,151,000
5,611,000
1,282,000
254,000
214,000
172,000
126,000
84,000
83,000
168,000
298,000
452,000
574,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.